Literature DB >> 15701100

Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors.

D Justo1, V Prokhorov, K Heller, D Zeltser.   

Abstract

OBJECTIVE: To investigate all published case reports of torsade de pointes (TdP) induced by psychotropic drugs (PDs) in order to examine the prevalence of risk factors for TdP prior to the drug initiation.
METHOD: We found 45 reports on 70 patients with TdP induced by PDs. Each report was analyzed for the presence of risk factors for TdP: female gender, heart disease, hypokalemia, high doses of offending agent, concomitant use of a QT interval prolonging agent, and a history of long-QT syndrome.
RESULTS: Female gender was the most common risk factor for TdP (71.4%). The other studied risk factors were also frequently present (34.2-14.2%). Nearly all patients had at least one and 51 (73%) patients had >2 risk factors for TdP prior to PD initiation.
CONCLUSION: We wish to raise the level of awareness of risk factors for TdP in the psychiatric community. Copyright (c) Blackwell Munksgaard 2005

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15701100     DOI: 10.1111/j.1600-0447.2004.00469.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.

Authors:  Alex F Manini; Dara Raspberry; Robert S Hoffman; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2007-12

2.  Molecular analysis of potassium ion channel genes in sudden death cases among patients administered psychotropic drug therapy: are polymorphisms in LQT genes a potential risk factor?

Authors:  Sayako Kamei; Noriko Sato; Yuta Harayama; Miyako Nunotani; Kanae Takatsu; Tetsuya Shiozaki; Tokutaro Hayashi; Hideki Asamura
Journal:  J Hum Genet       Date:  2013-11-28       Impact factor: 3.172

3.  Lack of relationship between plasma levels of escitalopram and QTc-interval length.

Authors:  Mar Carceller-Sindreu; Javier de Diego-Adeliño; Maria J Portella; Xavier Garcia-Moll; Maria Figueras; Aina Fernandez-Vidal; Josep M Queraltó; Dolors Puigdemont; Enric Álvarez
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-01-23       Impact factor: 5.270

4.  Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.

Authors:  Andrew J Muzyk; Amber Rayfield; Jane Y Revollo; Heather Heinz; Jane P Gagliardi
Journal:  Drug Saf       Date:  2012-07-01       Impact factor: 5.606

5.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

Review 6.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

7.  Implementation of a delirium assessment tool in the ICU can influence haloperidol use.

Authors:  Mark van den Boogaard; Peter Pickkers; Hans van der Hoeven; Gabriel Roodbol; Theo van Achterberg; Lisette Schoonhoven
Journal:  Crit Care       Date:  2009-08-10       Impact factor: 9.097

Review 8.  A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Authors:  Peter A G M De Smet; Wilma Denneboom; Cees Kramers; Richard Grol
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

9.  An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.

Authors:  Stefan Dhein; Franziska Perlitz; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-22       Impact factor: 3.000

10.  Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.

Authors:  Gary R Mirams; Yi Cui; Anna Sher; Martin Fink; Jonathan Cooper; Bronagh M Heath; Nick C McMahon; David J Gavaghan; Denis Noble
Journal:  Cardiovasc Res       Date:  2011-02-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.